Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation
Benjamin A. Nacev(University of Pittsburgh), C. David Allis(Rockefeller University)
Cited by 11
Related Papers
Histone and chromatin cross-talk
|Current Opinion in Cell Biology|2003|1.2k
A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin–MLL Inhibition
|Cancer Discovery|2022|78
A Calcineurin-Independent Mechanism of Angiogenesis Inhibition by a Nonimmunosuppressive Cyclosporin A Analog
|Journal of Pharmacology and Experimental Therapeutics|2011|26